Tariffs hit drugs and furniture

Summary

Beyond steel, aluminum, and autos, Commerce opened and imposed new Section 232 tariffs across sectors, including a 100% tariff on branded and patented pharmaceuticals announced September 25, 2025, plus tariffs on heavy trucks, furniture, lumber and timber, and certain advanced semiconductors. Further investigations span medical devices, robotics, aircraft, and machine tools.

What happened

The administration expanded Section 232 tariffs well beyond steel, aluminum, and autos. On September 25, 2025, it announced a 100% tariff on branded and patented pharmaceuticals for October 1, but the tariff did not take effect then; Proclamation 11020 of April 2, 2026 set a 100% duty on patented pharmaceuticals (20% for companies with approved onshoring plans, 15% for the EU, Japan, South Korea and Switzerland, 10% for the UK), effective July 31, 2026 for listed companies and September 29, 2026 for others. Commerce also imposed tariffs on heavy trucks, furniture, lumber and timber, and certain advanced semiconductors, and opened investigations spanning medical devices, robotics, aircraft, and machine tools. The measures broaden tariff coverage across major consumer and industrial categories.

Impact on the United States

Raises consumer prices on prescription drugs, furniture, and building materials, worsening housing and construction costs, while the drug-tariff risk threatens medicine affordability and supply.

Documented effects

1. Sep 2025100% tariff on branded and patented pharmaceuticals announced Sept 25, 2025, formalized April 2, 2026[1][2][4]
2. New tariffs added on heavy trucks, furniture, lumber/timber, and a 25% tariff on certain advanced semiconductors[2][3][5][6][7]

Why this is rated severe

Broad sector tariffs on pharmaceuticals, trucks, furniture, lumber and advanced chips extend tariff coverage across major consumer and industrial categories bought by US households and businesses.

Corrections & updates [4]

Every change to a fact on this page after publication is logged here, newest first.

1. Sep 29, 2026CorrectedSummary

   The entry said the pharmaceutical tariff was "paused September 30, 2025 amid negotiations"; no cited source supports that date or reason. What the record shows: the 100% tariff announced for October 1, 2025 did not take effect then. Proclamation 11020 (April 2, 2026) set a 100% duty on patented pharmaceuticals, with 20% for companies with approved onshoring plans, 15% for the EU, Japan, South Korea and Switzerland/Liechtenstein, and 10% for the UK, effective July 31, 2026 for listed companies and September 29, 2026 for others.[1][4]

   + Show previous and current text- Hide previous and current text

   Previously

   The administration expanded Section 232 tariffs well beyond steel, aluminum, and autos. On September 25, 2025, it announced a 100% tariff on branded and patented pharmaceuticals (effective October 1), then paused September 30, 2025 amid negotiations, before being formalized in April 2026. Commerce also imposed tariffs on heavy trucks, furniture, lumber and timber, and certain advanced semiconductors, and opened investigations spanning medical devices, robotics, aircraft, and machine tools. The measures broaden tariff coverage across major consumer and industrial categories.

   Now

   The administration expanded Section 232 tariffs well beyond steel, aluminum, and autos. On September 25, 2025, it announced a 100% tariff on branded and patented pharmaceuticals for October 1, but the tariff did not take effect then; Proclamation 11020 of April 2, 2026 set a 100% duty on patented pharmaceuticals (20% for companies with approved onshoring plans, 15% for the EU, Japan, South Korea and Switzerland, 10% for the UK), effective July 31, 2026 for listed companies and September 29, 2026 for others. Commerce also imposed tariffs on heavy trucks, furniture, lumber and timber, and certain advanced semiconductors, and opened investigations spanning medical devices, robotics, aircraft, and machine tools. The measures broaden tariff coverage across major consumer and industrial categories.

2. Sep 29, 2026ClarifiedSource

   Added the Federal Register proclamations for the timber/lumber and furniture tariffs (Proclamation 10976, Sept. 29, 2025), medium- and heavy-duty trucks (Proclamation 10984, Oct. 17, 2025) and the 25% tariff on certain advanced semiconductors (Proclamation 11002, Jan. 14, 2026). Corrected source dates: the Alston & Bird alert is dated September 28, 2025 and the White & Case alert January 21, 2026.[5][6][7]

3. Sep 29, 2026ClarifiedSeverity rationale

   The severity rationale stated a price effect ('push up prices') without a cited estimate; it now describes the scope of the tariffs. Severity unchanged.

   Previously

   Broad sector tariffs push up prices on medicine, furniture, and building materials for US households.

   Now

   Broad sector tariffs on pharmaceuticals, trucks, furniture, lumber and advanced chips extend tariff coverage across major consumer and industrial categories bought by US households and businesses.

4. Sep 29, 2026ClarifiedDisplay copy

   The summary asserted that the measures 'threaten medicine affordability' without a cited estimate; it now describes their scope, as the record does.

   + Show previous and current text- Hide previous and current text

   Previously

   Commerce expanded Section 232 tariffs far beyond metals and autos, including a 100% tariff on branded pharmaceuticals plus levies on heavy trucks, furniture, lumber, and advanced chips. The measures raise costs for drugs, housing, and construction, and threaten medicine affordability.

   Now

   Commerce expanded Section 232 tariffs far beyond metals and autos, including a 100% tariff on branded pharmaceuticals plus levies on heavy trucks, furniture, lumber, and advanced chips. The measures broaden tariff coverage across major consumer and industrial categories.

Sources [7]